Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in CYP2C19 loss-of -function carriers with minor stroke or transient ischaemic attack: a post-hoc analysis of the CHANCE-2 trialResearch in context
Summary: Background: The atherogenicity of remnant cholesterol (RC), a contributor to residual risk of cardiovascular events, has been underlined by recent guidelines. We aimed to evaluate the relationship between RC levels and the efficacy and safety of genotype-guided dual antiplatelet therapy in...
שמור ב:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2024-01-01
|
| סדרה: | EClinicalMedicine |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2589537023005345 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
